Cytokine-induced sickness behavior

被引:0
|
作者
Kelley, KW
Bluthé, RM
Dantzer, R
Zhou, JH
Shen, WH
Johnson, RW
Broussard, SR
机构
[1] Univ Illinois, Dept Anim Sci, Immunophysiol Lab, Urbana, IL 61801 USA
[2] Inst Francois Magendie, INSERM, INRA, U394,Unite Rech Neurobiol Integrat, F-33077 Bordeaux, France
[3] Univ Illinois, Dept Anim Sci, Lab Integrat Biol, Anim Sci Lab 390, Urbana, IL 61801 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The behavioral repertoire of humans and animals changes dramatically following infection. Sick individuals have little motivation to eat, are listless, complain of fatigue and malaise, loose interest in social activities and have significant changes in sleep patterns. They display an inability to experience pleasure, have exaggerated responses to pain and fail to concentrate. Proinflammatory cytokines acting in the brain cause sickness behaviors. These nearly universal behavioral changes are a manifestation of a central motivational state that is designed to promote recovery. Exaggerated symptoms of sickness in cancer patients, such as cachexia, can be life-threatening. However, quality of life is often drastically impaired before the cancer becomes totally debilitating. Although basic studies in psychoneuroimmunology have defined proinflammatory cytokines as the central mediators of sickness behavior, a much better understanding of how cytokine and neurotransmitter receptors communicate with each other is needed. Advances that have been made during the past decade should now be extended to clinical studies in an attempt to alleviate sickness symptoms and improve quality of life for cancer patients. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:S112 / S118
页数:7
相关论文
共 50 条
  • [1] Cytokine-induced sickness behavior: Mechanisms and implications
    Dantzer, R
    ROLE OF NEURAL PLASTICITY IN CHEMICAL INTOLERANCE, 2001, 933 : 222 - 234
  • [2] Twenty years of research on cytokine-induced sickness behavior
    Dantzer, Robert
    Kelley, Keith W.
    BRAIN BEHAVIOR AND IMMUNITY, 2007, 21 (02) : 153 - 160
  • [3] Cytokine-induced sickness behavior: Where do we stand?
    Dantzer, R
    BRAIN BEHAVIOR AND IMMUNITY, 2001, 15 (01) : 7 - 24
  • [4] Cytokine-induced sickness behaviour: mechanisms and implications
    Konsman, JP
    Parnet, P
    Dantzer, R
    TRENDS IN NEUROSCIENCES, 2002, 25 (03) : 154 - 159
  • [5] Detection of cytokine-induced sickness behavior after ischemic stroke by an optimized behavioral assessment battery
    Roth, Stefan
    Yang, Jun
    Cramer, Julia, V
    Malik, Rainer
    Liesz, Arthur
    BRAIN BEHAVIOR AND IMMUNITY, 2021, 91 : 668 - 672
  • [6] Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice
    Bluthé, RM
    Kelley, KW
    Dantzer, R
    BRAIN BEHAVIOR AND IMMUNITY, 2006, 20 (01) : 57 - 63
  • [7] Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
    Dantzer, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 500 (1-3) : 399 - 411
  • [8] Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia
    De La Garza, R
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (4-5): : 761 - 770
  • [9] Role of IL-6 in cytokine-induced sickness behavior:: a study with IL-6 deficient mice
    Bluthé, RM
    Michaud, B
    Poli, V
    Dantzer, R
    PHYSIOLOGY & BEHAVIOR, 2000, 70 (3-4) : 367 - 373
  • [10] Crosstalk between cytokine-induced apoptosis and cytokine-induced senescence in human cancer cells
    Burkhart, F.
    Rentschler, M.
    Weidemann, S.
    Braumueller, H.
    Bauer, B.
    Roecken, M.
    Wieder, T.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 (03) : E86 - E87